News Headlines Article

Q2 sales, profit improve for 3 major drugmakers
San Francisco Chronicle

Rising product sales helped three big drugmakers — Bristol-Myers Squibb Co., Roche Holding AG and Eli Lilly and Co. — post better second-quarter results on Thursday.

The three Top 20 pharmaceutical companies also confirmed or raised their 2010 profit forecasts, a move to reassure investors worried about the impact of the U.S. health care overhaul, the European economic crisis, shifting currency exchange rates and looming generic competition.